business
AstraZeneca and Bristol-Myers Held Merger Talks Through Summer
AstraZeneca engaged in discussions with Bristol-Myers Squibb through spring and summer, the Financial Times reports, signaling potential pharma consolidation.
AstraZeneca engaged in discussions with Bristol-Myers Squibb through spring and summer, the Financial Times reports, signaling potential pharma consolidation.
One concise briefing, weekly. No spam.
By subscribing you agree to receive periodic communications. Unsubscribe anytime via the link in each message or our Unsubscribe page.